Charles River Laboratories to Present at Evercore ISI Investor Conference
Charles River Laboratories (NYSE: CRL) announced its participation in the 7th Annual Evercore ISI HealthCONx Conference on Wednesday, December 4th, at 10:00 a.m. ET. During the event, the management will discuss strategic focus, business developments, and recent trends. A live webcast of the presentation will be accessible via the Investor Relations section of the Charles River website at ir.criver.com. The webcast replay will be available on the same site for at least two weeks post-presentation.
Charles River Laboratories (NYSE: CRL) ha annunciato la sua partecipazione alla 7ª Conferenza Annuale Evercore ISI HealthCONx che si terrà mercoledì 4 dicembre, alle 10:00 a.m. ET. Durante l'evento, la direzione discuterà del focus strategico, degli sviluppi aziendali e delle tendenze recenti. Una diretta streaming della presentazione sarà accessibile attraverso la sezione Investor Relations del sito web di Charles River all'indirizzo ir.criver.com. La registrazione della diretta sarà disponibile sullo stesso sito per almeno due settimane dopo la presentazione.
Charles River Laboratories (NYSE: CRL) anunció su participación en la 7ª Conferencia Anual Evercore ISI HealthCONx el miércoles 4 de diciembre a las 10:00 a.m. ET. Durante el evento, la dirección discutirá sobre el enfoque estratégico, desarrollos empresariales y tendencias recientes. Una transmisión en vivo de la presentación estará accesible a través de la sección de Relaciones con Inversores en el sitio web de Charles River en ir.criver.com. La repetición de la transmisión estará disponible en el mismo sitio durante al menos dos semanas después de la presentación.
찰스 리버 실험실 (NYSE: CRL)은 제7회 에버코어 ISI HealthCONx 컨퍼런스에 12월 4일 수요일 오전 10시(ET)에 참여한다고 발표했습니다. 행사 동안 경영진은 전략적 초점, 비즈니스 발전, 최근 트렌드에 대해 논의할 것입니다. 발표의 실시간 웹캐스트는 찰스 리버 웹사이트의 투자자 관계 섹션을 통해 ir.criver.com에서 시청할 수 있습니다. 웹캐스트 재방송은 발표 후 최소 2주 동안 동일한 사이트에서 제공될 것입니다.
Charles River Laboratories (NYSE: CRL) a annoncé sa participation à la 7ème Conférence Annuelle Evercore ISI HealthCONx qui se tiendra le mercredi 4 décembre à 10h00 ET. Lors de cet événement, la direction discutera de l'orientation stratégique, des dévéloppements commerciaux et des tendances récentes. Un webinaire en direct de la présentation sera accessible via la section Relations Investisseurs du site web de Charles River à l'adresse ir.criver.com. Le replay du webinaire sera disponible sur le même site pendant au moins deux semaines après la présentation.
Charles River Laboratories (NYSE: CRL) gab seine Teilnahme an der 7. jährlichen Evercore ISI HealthCONx-Konferenz am Mittwoch, den 4. Dezember, um 10:00 Uhr ET bekannt. Während der Veranstaltung wird das Management über strategische Schwerpunkte, Unternehmensentwicklungen und aktuelle Trends sprechen. Ein Live-Stream der Präsentation wird über den Bereich Investor Relations auf der Website von Charles River unter ir.criver.com zugänglich sein. Die Aufzeichnung des Live-Streams wird auf derselben Seite mindestens zwei Wochen nach der Präsentation verfügbar sein.
- None.
- None.
A live webcast of the presentation will be available through a link that will be posted on the Investor Relations section of the Charles River website at ir.criver.com. A webcast replay will be accessible through the same website after the presentation and will remain available for at least two weeks.
About Charles River
Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241202150673/en/
Investor Relations Contact:
Todd Spencer
Corporate Vice President, Investor Relations
781.222.6455
todd.spencer@crl.com
Source: Charles River Laboratories International, Inc.
FAQ
When will Charles River Laboratories present at the Evercore ISI HealthCONx Conference?
What will be discussed by Charles River Laboratories at the Evercore ISI HealthCONx Conference?
Where can I watch the live webcast of Charles River Laboratories' presentation?
How long will the webcast replay of Charles River Laboratories' presentation be available?
